Acasti Pharma reported $-3090000 in Operating Profit for its fiscal quarter ending in June of 2025.


Operating Profit Change Date
Acasti Pharma USD -3090000 614K Jun/2025
Addus HomeCare USD 32.89M 2.37M Jun/2025
Amarin USD -16755000 35.77M Mar/2025
Cassava Sciences USD -14090000 15.4M Jun/2025
Knight Therapeutics CAD 3.2M 1.29M Sep/2024
Option Care Health USD 82.71M 3.52M Jun/2025
Organigram Holdings CAD -2100000 9.2M Jun/2025
Tilray USD -42218000 5.65M Nov/2024